On July 11, a prominent PEGUS Research sponsor submitted its application to the FDA for a first-ever over-the-counter (OTC) oral contraceptive in the US. PEGUS has worked closely with the sponsor to develop and conduct the research to make this important product available without a prescription. PEGUS is proud to support the sponsor’s efforts and warmly congratulates the sponsor on reaching this significant milestone.
For additional information, please see the article here.
